2023
DOI: 10.1016/j.modpat.2022.100070
|View full text |Cite
|
Sign up to set email alerts
|

PDGFRB and NOTCH3 Mutations are Detectable in a Wider Range of Pericytic Tumors, Including Myopericytomas, Angioleiomyomas, Glomus Tumors, and Their Combined Tumors

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 35 publications
0
6
0
Order By: Relevance
“…Preliminary research has indicated that genetic modifications involve BRAF, NOTCH, PDGFRB, KRAS, and SMARCB1 [ 18 , 35 , 36 , 37 , 38 ]. Moreover, certain authors propose a traumatic etiology, drawing from a documented case involving a digital glomangioma [ 39 ].…”
Section: General Information and Histopathological Considerationsmentioning
confidence: 99%
“…Preliminary research has indicated that genetic modifications involve BRAF, NOTCH, PDGFRB, KRAS, and SMARCB1 [ 18 , 35 , 36 , 37 , 38 ]. Moreover, certain authors propose a traumatic etiology, drawing from a documented case involving a digital glomangioma [ 39 ].…”
Section: General Information and Histopathological Considerationsmentioning
confidence: 99%
“…After a thorough literature search of the PubMed and Google Scholar databases, only 10 previous cases of finger MPCs were found (refer to Though the etiopathogenesis of MPCs is still largely unknown, recent studies have revealed some genetic abnormalities, such as platelet-derived growth factor receptor-beta (PDGFRB) mutations, NOTCH receptor 3 (NOTCH3) mutations, serum response factor, and NOTCH rearrangements as being associated with various pericytic tumors. Among these genetic abnormalities, PDGFRB somatic mutations are associated with sporadic myopericytomas [12]. However, some authors have proposed trauma [13] and AIDS as possible triggers [14].…”
Section: Case Presentationmentioning
confidence: 99%
“…2 The genetic landscape of glomus tumors is still being elucidated. [3][4][5][6][7][8] CARMN::NOTCH1-3 fusions were first described in 2013 by Mosquera et al, 3 with NOTCH2 fusions predominating over NOTCH1 and NOTCH3 fusions. CARMN is a long-noncoding RNA that is expressed in vascular smooth muscle cells, and it contains MIR143 and MIR145 which were previously implicated specifically in NOTCH gene fusions.…”
Section: Introductionmentioning
confidence: 99%
“…Morphologically, malignant glomus tumors can show a malignant spindled morphology resembling leiomyosarcoma or fibrosarcoma or may consist of sheets of malignant round cells 2 . The genetic landscape of glomus tumors is still being elucidated 3–8 . CARMN::NOTCH1‐3 fusions were first described in 2013 by Mosquera et al, 3 with NOTCH2 fusions predominating over NOTCH1 and NOTCH3 fusions.…”
Section: Introductionmentioning
confidence: 99%